Development of a prognostic Risk Classification for biochemical Recurrence after PSMA-PET-based Radiotherapy in Patients with oligometastatic Prostate Cancer.
Strahlenther. Onkol.195, S30-S31 (2019)
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.